Insmed Incorporated

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About INSM

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. 

CEO
William H. Lewis
CEOWilliam H. Lewis
Employees
1,271
Employees1,271
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
1988
Founded1988
Employees
1,271
Employees1,271

INSM Key Statistics

Market cap
37.11B
Market cap37.11B
Price-Earnings ratio
-28.16
Price-Earnings ratio-28.16
Dividend yield
Dividend yield
Average volume
5.10M
Average volume5.10M
High today
$175.24
High today$175.24
Low today
$173.24
Low today$173.24
Open price
$174.18
Open price$174.18
Volume
1.74M
Volume1.74M
52 Week high
$212.75
52 Week high$212.75
52 Week low
$60.40
52 Week low$60.40

Stock Snapshot

With a market cap of 37.11B, Insmed Incorporated(INSM) trades at $174.04. The stock has a price-to-earnings ratio of -28.16.

During the trading session on 2026-01-01, Insmed Incorporated(INSM) shares reached a daily high of $175.24 and a low of $173.24. At a current price of $174.04, the stock is +0.5% higher than the low and still -0.7% under the high.

Trading volume for Insmed Incorporated(INSM) stock has reached 1.74M, versus its average volume of 5.1M.

The stock's 52-week range extends from a low of $60.40 to a high of $212.75.

The stock's 52-week range extends from a low of $60.40 to a high of $212.75.

INSM News

Nasdaq 5d
INSM Quantitative Stock Analysis

Below is Validea's guru fundamental report for INSMED INC (INSM). Of the 22 guru strategies we follow, INSM rates highest using our Quantitative Momentum Invest...

INSM Quantitative Stock Analysis

Analyst ratings

95%

of 20 ratings
Buy
95%
Hold
5%
Sell
0%

People also own

Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.